Stock Research for ARYX

Current Price


Latest Update: 2018-02-16 14:21:00

$ 0.0025
$ 0.0025
$ 0.0025

Featured Broker: TradeStation

Get the due diligence for another stock.


ARYX Stock Chart & Research Data

The ARYX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ARYX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


ARYX Due diligence Resources & Stock Charts

The ARYX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View ARYX Detailed Price Forecast - CNN Money CNN View ARYX Detailed Summary - Google Finance
Yahoo View ARYX Detailed Summary - Yahoo! Finance Zacks View ARYX Stock Research & Analysis -

Stock Analysis

TradeIdeas View ARYX Trends & Analysis - Trade-Ideas Barrons View ARYX Major Holders - Barrons
NASDAQ View ARYX Call Transcripts - NASDAQ Seeking View ARYX Breaking News & Analysis - Seeking Alpha
Spotlight View ARYX Annual Report - OTC Report View ARYX OTC Short Report -
TradeKing View ARYX Fundamentals - TradeKing Charts View ARYX SEC Filings - Bar Chart
WSJ View Historical Prices for ARYX - The WSJ Morningstar View Performance/Total Return for ARYX - Morningstar
MarketWatch View the Analyst Estimates for ARYX - MarketWatch CNBC View the Earnings History for ARYX - CNBC
StockMarketWatch View the ARYX Earnings - StockMarketWatch MacroAxis View ARYX Buy or Sell Recommendations - MacroAxis
Bullish View the ARYX Bullish Patterns - American Bulls Short Pains View ARYX Short Pain Metrics -

Social Media Mentions

StockTwits View ARYX Stock Mentions - StockTwits PennyStocks View ARYX Stock Mentions - PennyStockTweets
Twitter View ARYX Stock Mentions - Twitter Invest Hub View ARYX Investment Forum News - Investor Hub
Yahoo View ARYX Stock Mentions - Yahoo! Message Board Seeking Alpha View ARYX Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for ARYX - Insider Cow View Insider Transactions for ARYX - Insider Cow
CNBC View ARYX Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for ARYX - OTC Markets
Yahoo View Insider Transactions for ARYX - Yahoo! Finance NASDAQ View Institutional Holdings for ARYX - NASDAQ

Stock Charts

FinViz View ARYX Stock Insight & Charts - StockCharts View ARYX Investment Charts -
BarChart View ARYX Stock Overview & Charts - BarChart Trading View View ARYX User Generated Charts - Trading View

Latest Financial News for ARYX

Posted on Wednesday December 31, 1969

Posted on Wednesday December 31, 1969

Posted on Wednesday December 31, 1969

Posted on Wednesday December 31, 1969

This Week's Pharma IPO: ARYx Therapeutics
Seeking Alpha (blog) - Nov 5, 2007
ARYx Therapeutics (OTCPK:ARYX), a specialty pharmaceutical company focused on retrometabolic drug design, is going public this week.

ARYx Therapeutics will close shop after FDA delay scuttles financing
FierceBiotech - Mar 10, 2011
RIP: ARYx Therapeutics. The biotech ($ARYX) plans to close shop, pinning the blame on the FDA's inability to deliver guidance on a critical trial design on schedule, which prompted investors to bail on an offer to provide an extra injection of cash.

Braeburn Pharmaceuticals expands pipeline to include two schizophrenia treatments
PR Newswire (press release) - May 1, 2015
ATI-9242 was designed by Aryx Therapeutics, Inc. to have many of the benefits of clozapine but without the well-documented adverse effects of clozapine.

Alpine Immune Sciences Names Dr. Stanford Peng Executive Vice President and ...
Business Wire (press release) - Sep 16, 2016
SEATTLE--(BUSINESS WIRE)--Alpine Immune Sciences, Inc. (AIS), a privately held biotechnology company developing a next-generation immune system modulation platform, today announced the appointment of Stanford Peng, M.D.

Enter a stock symbol to view the stock details.